DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Exor - 3 Roy Jakobs - 3 Philips - 3 Italy's Agnelli - 3 John Elkann - 2 Toby Sterling - 2 Valentina Za - 2 Elkann - 1
Top related locs:
TURIN AMSTERDAM Turin U.S Philips Dutch , Netherlands Exor
Top related orgs:
Philips - 3 Thomson - 3 Exor - 2 Exor NV - 1 Philips NV - 1 U.S . Food - 1 Drug Administration - 1 Investment - 1

Search resuls for: "Italy's Agnelli"


6 mentions found


☆ Philips investor Exor: company's problems are "solvable"
  + stars: | 2023-11-30 | by ( Giulio Piovaccari | ) www.reuters.com   time to read: +2 min
TURIN/AMSTERDAM, Nov 30 (Reuters) - The CEO of Exor NV (EXOR.AS), the largest shareholder in Dutch healthcare equipment maker Philips NV (PHG.AS), on Thursday said he continues to believe the company's problems are solvable. Exor owns a 15% stake in Philips. The recall wiped nearly two-thirds off Philips' stock market valuation and new CEO Roy Jakobs has said that resolving the issue is his top priority. Philips stock is currently trading at 18.77 euros, about 25 cents higher than before Exor announced its investment in August. Exor is the investment arm of Italy's Agnelli family, with investments in manufacturing, sport, media, fashion, healthcare and technology companies.
Persons: John Elkann, Exor, Elkann, Roy Jakobs, Philips, Italy's Agnelli, Guilio Piovaccari, Toby Sterling, Kirsten Donovan Organizations: Exor NV, Philips NV, U.S . Food, Drug Administration, Philips, Exor, Thomson Locations: TURIN, AMSTERDAM, Turin, U.S
☆ Goldman Sachs used derivatives to help Exor build $2.8 bln Philips stake, filings show
  + stars: | 2023-08-17 | by ( Tosterling Pablo Mayo Cerqueiro Andres Gonzalez | Pablo Mayo Cerqueiro | Andres Gonzalez | ) www.reuters.com   time to read: +2 min
AMSTERDAM, Aug 17 (Reuters) - Investment company Exor (EXOR.AS) was able to build a 15% stake in Dutch healthcare group Philips (PHG.AS) without triggering the usual disclosures thanks to derivatives deals through Goldman Sachs, regulatory filings show. Exor's investment was seen as a vote of confidence in Philips and boosted the Dutch company's shares. Filings by the Dutch Financial Market Authority AFM dated Aug. 14 but published late on Wednesday showed Goldman Sachs had taken an 12.11% stake in Philips using a derivatives structure that included 95 million call options. Sources confirmed to Reuters earlier this week that Goldman Sachs acted on behalf of Exor but could not give more details. Exor and Goldman Sachs (GS.N) declined to comment.
Persons: Goldman Sachs, Italy's Agnelli, Roy Jakobs, Exor, Allen, Overy, De Brauw, Philips, Toby Sterling, Pablo Mayo Cerqueiro, Andres Gonzalez, Valentina Za, Victoria Farr, Jane Merriman Organizations: Investment, Philips, Dutch, US Securities and Exchange, Reuters, Overy, Thomson Locations: Philips, Dutch
☆ Agnelli family's Exor buys $2.8 bln stake in Philips
  + stars: | 2023-08-14 | by ( Tosterling Bart H. Meijer | Bart H. Meijer | ) www.reuters.com   time to read: +3 min
[1/2] Philips Healthcare headquarters is seen in Best, Netherlands August 30, 2018. The group combines two of the three sectors Exor targets in its investment strategy: healthcare and technology. While not an activist investor, Exor aims to play an active role in supporting Philips' strategy, the source said. "Exor's substantial investment underlines their confidence in Philips' transformation into a healthcare technology company and its growth and value potential," Philips Chairman Feike Sijbesma said in a statement. Philips last month reported core profit of 453 million euros and slightly upgraded financial targets for the full year.
Persons: de, Exor, Italy's Agnelli, Philips, Feike Sijbesma, John Elkann, Lifenet, Louboutin, Roy Jakobs, Valentina Za, Kim Coghill, David Goodman, Susan Fenton Organizations: Philips Healthcare, REUTERS, Philips, Philips AMSTERDAM, Exor, Institut, Ferrari, Italian soccer, Juventus, ING, U.S . Department of Justice, Thomson Locations: , Netherlands, Exor, Louboutin . New York, Italian, Milan
☆ Agnellis' Exor eyes further healthcare investment for expansion
  + stars: | 2023-04-17 | by ( Giulio Piovaccari | ) www.reuters.com   time to read: +2 min
After completing the sale of its reinsurer PartnerRE, Exor has around 6.5 billion euros in cash available for investments, including 5 billion euros for acquisitions. It has already said its M&A activity would mainly focus on healthcare, luxury and technology businesses. Through its venture capital arm Exor Ventures, Exor was also developing partnerships with healthcare companies at an early stage of their development, Elkann said. NEW CHAIRMANExor is the single largest investor in carmaker Stellantis and has controlling stakes in companies including Ferrari (RACE.MI), CNH Industrial (CNHI.MI) and soccer club Juventus (JUVE.MI). It said its profit rose to 4.227 billion euros ($4.64 billion) last year, from 1.717 billion euros in 2021 mainly due to the net gain it booked from the 8.6 billion euro sale of PartnerRe.
☆ Exor picks Nohria as new chairman to succeed World Bank nominee Banga
  + stars: | 2023-04-17 | by ( ) www.reuters.com   time to read: +2 min
Netherlands-based Exor has proposed Nitin Nohria as its new non-executive chairman, it said in a statement as it presented its full-year results. It said its profit rose to 4.227 billion euros ($4.64 billion) last year, from 1.717 billion euros in 2021. The holding company's net asset value (NAV) amounted to 28.233 billion euros at the end of 2022, 9.1% lower then a year earlier. Exor proposed an ordinary dividend of 100 million euros, or 0.44 euros per share. Exor said that in the first months of 2023 it had increased investments in its private funds strategies by 400 million euros and committed for a further 300 million euros.
☆ Juventus has no requirement of additional capital, says Exor's Elkann
  + stars: | 2022-11-30 | by ( Daniel Wiessner | ) www.reuters.com   time to read: +1 min
MILAN, Nov 30 (Reuters) - Serie A soccer club Juventus (JUVE.MI) does not need a fresh capital injection, the chief executive of controlling shareholder Exor (EXOR.AS) said on Wednesday. Exor on Tuesday proposed accountant Gianluca Ferrero as the new chairman of Juventus, marking the end of the long reign of Andrea Agnelli as the Italian soccer club tries to get to grips with its financial and legal troubles. "Juventus has no requirement of capital," Exor CEO John Elkann told analysts and investors at a business presentation of the holding company of Italy's Agnelli family. "Football is a very valuable sector, the ingredients that Juventus has and the leadership ahead are going to make the differences," Elkann said, adding Exor was very encouraged by the future of the club. Reporting by Giulio Piovaccari Editing by Keith WeirOur Standards: The Thomson Reuters Trust Principles.
0 next >>
Total: 6